Daniel Meibom

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Venues

Journal of medicinal chemistry

ACS omega

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Meibom, Pierre Wasnaire, Kristin Beyer, Andreas Broehl, Yolanda Cancho-Grande, Nadine Elowe, Kerstin Henninger, Sarah Johannes, Natalia Jungmann, Tanja Krainz, Niels Lindner, Stefanie Maassen, Bryan T MacDonald, Denis Menshykau, Joachim Mittendorf, Guzman Sanchez, Martina Schaefer, Eric Stefan, Afra Torge, Yi Xing, Dmitry Zubov
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor. Journal of medicinal chemistry (2024)
Daniel Meibom, Pierre Wasnaire, Kristin Beyer, Andreas Broehl, Yolanda Cancho-Grande, Nadine Elowe, Kerstin Henninger, Sarah Johannes, Natalia Jungmann, Tanja Krainz, Niels Lindner, Stefanie Maassen, Bryan T MacDonald, Denis Menshykau, Joachim Mittendorf, Guzman Sanchez, Martina Schaefer, Eric Stefan, Afra Torge, Yi Xing, Dmitry Zubov
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor. Journal of medicinal chemistry 67 (4) (2024)
Daniel Meibom, Pierre Wasnaire, Kristin Beyer, Andreas Broehl, Yolanda Cancho-Grande, Nadine Elowe, Kerstin Henninger, Sarah Johannes, Natalia Jungmann, Tanja Krainz, Niels Lindner, Stefanie Maassen, Bryan T MacDonald, Denis Menshykau, Joachim Mittendorf, Guzman Sanchez, Martina Schaefer, Eric Stefan, Afra Torge, Yi Xing, Dmitry Zubov
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor. Journal of medicinal chemistry 67 (4) (2024)
Daniel Meibom, Pierre Wasnaire, Kristin Beyer, Andreas Broehl, Yolanda Cancho-Grande, Nadine Elowe, Kerstin Henninger, Sarah Johannes, Natalia Jungmann, Tanja Krainz, Niels Lindner, Stefanie Maassen, Bryan T MacDonald, Denis Menshykau, Joachim Mittendorf, Guzman Sanchez, Martina Schaefer, Eric Stefan, Afra Torge, Yi Xing, Dmitry Zubov
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor. Journal of medicinal chemistry 67 (4) (2024)
Daniel Meibom, Pierre Wasnaire, Kristin Beyer, Andreas Broehl, Yolanda Cancho-Grande, Nadine Elowe, Kerstin Henninger, Sarah Johannes, Natalia Jungmann, Tanja Krainz, Niels Lindner, Stefanie Maassen, Bryan T MacDonald, Denis Menshykau, Joachim Mittendorf, Guzman Sanchez, Martina Schaefer, Eric Stefan, Afra Torge, Yi Xing, Dmitry Zubov
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor. Journal of medicinal chemistry 67 (4) (2024)
Susanne Roehrig, Jens Ackerstaff, Eloísa Jiménez Núñez, Henrik Teller, Pascal Ellerbrock, Katharina Meier, Stefan Heitmeier, Adrian Tersteegen, Jan Stampfuss, Dieter Lang, Karl-Heinz Schlemmer, Martina Schaefer, Kersten M Gericke, Tom Kinzel, Daniel Meibom, Martina Schmidt, Christoph Gerdes, Markus Follmann, Alexander Hillisch
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. Journal of medicinal chemistry (2023)
Vasanthanathan Poongavanam, Florian Kölling, Anja Giese, Andreas H Göller, Lutz Lehmann, Daniel Meibom, Jan Kihlberg
Predictive Modeling of PROTAC Cell Permeability with Machine Learning. ACS omega 8 (6) (2023)
Daniel Meibom, Jutta Meyer, Clemens-Jeremias von Buehler, Karl D Collins, Stefanie Maassen, Kersten Matthias Gericke, Jörg Hüser, Joachim Mittendorf, Nuria Ortega Hernandez, Jens Schamberger, Jan Stampfuss, Alexander Straub, Afra Torge, Norbert Witowski, Frank Wunder
BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α 2B Antagonist. Journal of medicinal chemistry (2023)
Vasanthanathan Poongavanam, Florian Kölling, Anja Giese, Andreas H Göller, Lutz Lehmann, Daniel Meibom, Jan Kihlberg
Predictive Modeling of PROTAC Cell Permeability with Machine Learning. ACS omega 8 (6) (2023)
Daniel Meibom, Sina Micus, Anna Lena Andreevski, Sonja Anlauf, Pamela Bogner, Clemens-Jeremias von Buehler, André P Dieskau, Jan Dreher, Frank Eitner, Daniela Fliegner, Markus Follmann, Kersten Matthias Gericke, Stefanie Maassen, Jutta Meyer, Karl-Heinz Schlemmer, Holger Steuber, Adrian Tersteegen, Frank Wunder
BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Journal of medicinal chemistry 65 (24) (2022)
Daniel Meibom, Sina Micus, Anna Lena Andreevski, Sonja Anlauf, Pamela Bogner, Clemens-Jeremias von Buehler, André P Dieskau, Jan Dreher, Frank Eitner, Daniela Fliegner, Markus Follmann, Kersten Matthias Gericke, Stefanie Maassen, Jutta Meyer, Karl-Heinz Schlemmer, Holger Steuber, Adrian Tersteegen, Frank Wunder
BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Journal of medicinal chemistry 65 (24) (2022)
Daniel Meibom, Sina Micus, Anna Lena Andreevski, Sonja Anlauf, Pamela Bogner, Clemens-Jeremias von Buehler, André P Dieskau, Jan Dreher, Frank Eitner, Daniela Fliegner, Markus Follmann, Kersten Matthias Gericke, Stefanie Maassen, Jutta Meyer, Karl-Heinz Schlemmer, Holger Steuber, Adrian Tersteegen, Frank Wunder
BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Journal of medicinal chemistry 65 (24) (2022)
Vasanthanathan Poongavanam, Yoseph Atilaw, Stephan Siegel, Anja Giese, Lutz Lehmann, Daniel Meibom, Máté Erdélyi, Jan Kihlberg
Linker-Dependent Folding Rationalizes PROTAC Cell Permeability. Journal of medicinal chemistry 65 (19) (2022)
Daniel Meibom, Sina Micus, Anna Lena Andreevski, Sonja Anlauf, Pamela Bogner, Clemens-Jeremias von Buehler, André P Dieskau, Jan Dreher, Frank Eitner, Daniela Fliegner, Markus Follmann, Kersten Matthias Gericke, Stefanie Maassen, Jutta Meyer, Karl-Heinz Schlemmer, Holger Steuber, Adrian Tersteegen, Frank Wunder
BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Journal of medicinal chemistry 65 (24) (2022)
Daniel Meibom, Sina Micus, Anna Lena Andreevski, Sonja Anlauf, Pamela Bogner, Clemens-Jeremias von Buehler, André P Dieskau, Jan Dreher, Frank Eitner, Daniela Fliegner, Markus Follmann, Kersten Matthias Gericke, Stefanie Maassen, Jutta Meyer, Karl-Heinz Schlemmer, Holger Steuber, Adrian Tersteegen, Frank Wunder
BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Journal of medicinal chemistry 65 (24) (2022)

Daniel Meibom.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Meibom